Tag: Claret Medical
Boston Scientific to buy cerebral protection system company
Boston Scientific has signed an agreement to acquire Claret Medical, which developed and commerciali...
ADVERTORIAL: Sentinel Cerebral Protection System provides reassurance to both physicians and patients
Compared with first-generation devices, new-generation transcatheter aortic valve implantation (...
ADVERTORIAL: “All patients” should receive cerebral protection when undergoing TAVI procedures
Data indicate that patients who undergo TAVI with the Sentinel Cerebral Protection System (Claret Me...
Fifty US centres are now using Claret Medical’s Sentinel cerebral protection system
Since it received FDA clearance in June 2017, the Sentinel cerebral protection system (Claret Me...
Claret Medical closes on series C financing of US$14.5m
Claret Medical has announced that it has closed on a series C financing of US$14.5m led by Light...
All-comers data indicate stroke-free survival is improved with Sentinel embolic protection device
Jochen Wöhrle (Department of Internal Medicine II, Cardiology, University of Ulm, Ulm, Germany) ...
US centres of TAVI excellence start to use newly approved Sentinel device
Claret Medical has announced that several of the largest centres of excellence for transcatheter...
Sentinel becomes first cerebral protection device to receive FDA approval
Claret Medical has received regulatory clearance from the FDA for its Sentinel cerebral protecti...
TCT 2016: SENTINEL trial fails to meet overall primary efficacy endpoint but does in adjusted model
The SENTINEL trial, which was presented at the 2016 Transcatheter Cardiovascular Therapeutics (T...
Claret Medical submits application for FDA approval of its cerebral protection device
Claret Medical has announced its filing of a marketing application with the FDA for clearance of...
